Will the future of lung cancer biomarkers be based on deep learning and #AI? Deep learning model predicts response to immunotherapy in NSCLC from one histology slide and performed better than TMB, PD-L1. Report now in JAMA Oncology.
jamanetwork.com/journals/jam...
jamanetwork.com
Deep Learning Model for Predicting Immunotherapy Response in Advanced NSCLC
This multicenter cohort study develops and assesses the validity of a deep learning model for predicting immune checkpoint inhibitor response in patients with advanced non−small cell lung cancer.
